Medicine and Dentistry
Atrial Fibrillation
77%
Pulmonary Vein Isolation
71%
Catheter Ablation
66%
Heart Left Ventricle Ejection Fraction
38%
Anticoagulation
35%
Systolic Heart Failure
33%
Bone Mass
33%
Ventricular Fibrillation
33%
Protein Degradation
33%
Skeletal Muscle
33%
Atrial Fibrillation Ablation
33%
Intracardiac Echocardiography
33%
Persistent Atrial Fibrillation
33%
Heart Failure with Reduced Ejection Fraction
33%
Cardiac Sarcoidosis
33%
Heart Failure
33%
T Wave
33%
Ventricular Tachycardia
33%
Takotsubo Cardiomyopathy
33%
Dabigatran
33%
Biological Marker
33%
Catheter Ablation
25%
T Wave Amplitude
23%
Antithrombotic
22%
Vitamin K Antagonist
22%
Activated Clotting Time
22%
Cryoablation
20%
Brain Natriuretic Peptide
19%
Thromboembolism
18%
Cardiac Magnetic Resonance Imaging
17%
Blood Clotting Factor 10a Inhibitor
16%
Creatinine
14%
Repolarization
14%
Lower Limb
14%
Multivariate Analysis
13%
Anticoagulant
13%
Magnetic Resonance Imaging
13%
Left Ventricular Systolic Dysfunction
11%
Apixaban
11%
Muscle Atrophy
9%
Heart Rate Variability
9%
Inflammatory Cytokine
9%
Interleukin 6
9%
C Reactive Protein
9%
Acute Coronary Syndrome
9%
Fibrinolysis
7%
Paroxysmal Atrial Fibrillation
5%
Heart Muscle Injury
5%
Serositis
5%
Keyphrases
Effectiveness Comparison
33%
Small RNA Sequencing
33%
Atrial Fibrillation Progression
33%
Multiple Wavelet
33%
Intracardiac Echocardiography
33%
Damage Event
33%
Cardiac Sarcoidosis
33%
INR Control
33%
Supratherapeutic
33%
Ablation Index
33%
PT-INR
33%
Heart Failure with Preserved Ejection Fraction (HFpEF)
33%
Preserved Ejection Fraction
33%
Skeletal muscle Proteolysis
33%
Takotsubo Cardiomyopathy
33%
Stable Cardiovascular Disease
33%
Left Atrial Appendage Thrombus
33%
Coagulation Biomarkers
33%
Force-time Integral
25%
Activated Clotting Time
22%
Cardiac Magnetic Resonance Imaging (cMRI)
17%
Late Gadolinium Enhancement
17%
Silent Cerebral Infarction
16%
Physical Trigger
14%
AF Recurrence
12%
Persistent AF
11%
Apixaban
11%
Transesophageal Echocardiography
10%
Atrial Fibrillation Heart Failure
8%
Myocardial Scar
7%
Time Kinetics
5%
Random Forest Regression
5%
Prognostic Role
5%
Random Forest Method
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Inflammation
46%
Systolic Heart Failure
33%
Rivaroxaban
33%
Acetylsalicylic Acid
33%
Biological Marker
33%
Cardiovascular Disease
33%
Heart Failure
33%
Heart Failure with Reduced Ejection Fraction
33%
Cardiac Sarcoidosis
33%
Left Ventricular Systolic Dysfunction
33%
Direct Oral Anticoagulant
33%
Thromboembolism
28%
Anticoagulant Agent
25%
Brain Natriuretic Peptide
19%
Antivitamin K
16%
Creatinine
14%
Paroxysmal Atrial Fibrillation
13%
Heart Muscle Injury
13%
Apixaban
11%
Interleukin 6
9%
Cytokine
9%
C Reactive Protein
9%
Muscle Atrophy
9%
Prothrombin
6%
D Dimer
6%
Creatine Kinase MB
6%
Plasmin
6%
Plasmin Inhibitor
6%
Troponin I
6%
Bleeding
6%
